Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cardiff Oncology, Inc. CRDF

Full chart Compare
Set alert

Price alert · CRDF

All alert types
0.87 USD +0.01 (+0.67%)

At closeNov 4, 2026, 4:12 PM EST

0.89 +0.02 +1.99%

After hours · Nov 4, 4:12 PM ET

0.8435 Day range 0.90
0.76 52-week range 3.31
YTD
-69.08%
1 year
-60.86%

Financial health

Altman Z-Score

-15.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -4.1×
FY 2016: -1.6×FY 2017: -0.4×FY 2018: -0.5×FY 2019: -0.5×FY 2020: -16.7×FY 2021: -8.2×FY 2022: -1.6×FY 2023: -1.6×FY 2024: -4.6×FY 2025: -4.1×
FY 2016 5y median -4.1× FY 2025
P/S 317×
FY 2016: 166×FY 2017: 21.3×FY 2018: 19.6×FY 2019: 30.3×FY 2020: 1026×FY 2021: 653×FY 2022: 158×FY 2023: 135×FY 2024: 303×FY 2025: 317×
FY 2016 5y median 303× FY 2025
P/B 4.1×
FY 2016: 3.2×FY 2017: 1.7×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 2.9×FY 2021: 1.7×FY 2022: 0.6×FY 2023: 0.9×FY 2024: 2.5×FY 2025: 4.1×
FY 2016 5y median 1.7× FY 2025
P/FCF -4.9×
FY 2016: -2.0×FY 2017: -0.5×FY 2018: -0.6×FY 2019: -0.6×FY 2020: -22.7×FY 2021: -10.1×FY 2022: -1.8×FY 2023: -2.1×FY 2024: -5.5×FY 2025: -4.9×
FY 2016 5y median -4.9× FY 2025
EV/EBITDA -3.8×
FY 2016: -1.2×FY 2017: -0.2×FY 2018: 0.3×FY 2019: 0.1×FY 2020: -13.0×FY 2021: -8.1×FY 2022: -1.2×FY 2023: -1.1×FY 2024: -3.5×FY 2025: -3.8×
FY 2016 5y median -3.5× FY 2025
EV/Sales 289×
FY 2016: 110×FY 2017: 7.6×FY 2018: -10.7×FY 2019: -4.3×FY 2020: 671×FY 2021: 629×FY 2022: 123×FY 2023: 95.5×FY 2024: 230×FY 2025: 289×
FY 2016 5y median 230× FY 2025
FCF Yield -20.2%
FY 2016: -50.3%FY 2017: -217.5%FY 2018: -178.2%FY 2019: -180.0%FY 2020: -4.4%FY 2021: -9.9%FY 2022: -56.9%FY 2023: -47.6%FY 2024: -18.3%FY 2025: -20.2%
FY 2016 5y median -20.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: -354.1%FY 2017: -258.6%FY 2018: -57.9%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -8256.3%
FY 2016: -10536.7%FY 2017: -5068.5%FY 2018: -4511.4%FY 2019: -6817.8%FY 2020: -5214.8%FY 2021: -8037.6%FY 2022: -10337.3%FY 2023: -9305.7%FY 2024: -7123.1%FY 2025: -8256.3%
FY 2016 5y median -8256.3% FY 2025
Net Margin -7732.0%
FY 2016: -10289.8%FY 2017: -4932.1%FY 2018: -4354.8%FY 2019: -6709.7%FY 2020: -5275.1%FY 2021: -7880.5%FY 2022: -10026.9%FY 2023: -8492.0%FY 2024: -6651.7%FY 2025: -7732.0%
FY 2016 5y median -7880.5% FY 2025
ROE -101.0%
FY 2016: -198.3%FY 2017: -382.8%FY 2018: -163.2%FY 2019: -224.5%FY 2020: -15.1%FY 2021: -20.1%FY 2022: -36.4%FY 2023: -59.4%FY 2024: -54.8%FY 2025: -101.0%
FY 2016 5y median -54.8% FY 2025
ROIC -105.9%
FY 2016: -103.5%FY 2017: -264.7%FY 2018: -152.2%FY 2019: -181.9%FY 2020: -14.7%FY 2021: -20.1%FY 2022: -36.6%FY 2023: -63.2%FY 2024: -57.6%FY 2025: -105.9%
FY 2016 5y median -57.6% FY 2025
ROA -74.1%
FY 2016: -89.2%FY 2017: -202.7%FY 2018: -116.2%FY 2019: -125.4%FY 2020: -14.3%FY 2021: -18.9%FY 2022: -33.3%FY 2023: -50.8%FY 2024: -46.7%FY 2025: -74.1%
FY 2016 5y median -46.7% FY 2025

Growth (YoY)

Revenue -13.2%
FY 2016: 21.7%FY 2017: 32.5%FY 2018: -25.1%FY 2019: -35.3%FY 2020: 49.6%FY 2021: -1.9%FY 2022: 7.5%FY 2023: 26.4%FY 2024: 40.0%FY 2025: -13.2%
FY 2016 FY 2025
Operating Income -0.6%
FY 2016: -58.8%FY 2017: 36.2%FY 2018: 33.4%FY 2019: 2.2%FY 2020: -14.4%FY 2021: -51.2%FY 2022: -38.3%FY 2023: -13.8%FY 2024: -7.1%FY 2025: -0.6%
FY 2016 FY 2025
EPS (diluted) 27.4%
FY 2016: -24.7%FY 2017: 44.5%FY 2018: 86.3%FY 2019: 61.8%FY 2020: 60.0%FY 2021: 32.4%FY 2022: -21.9%FY 2023: -4.5%FY 2024: -2.2%FY 2025: 27.4%
FY 2016 FY 2025
Free Cash Flow -0.5%
FY 2016: -30.8%FY 2017: 26.6%FY 2018: 43.5%FY 2019: -1.0%FY 2020: -23.9%FY 2021: -40.7%FY 2022: -49.3%FY 2023: 9.3%FY 2024: -20.0%FY 2025: -0.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.7×
FY 2016: 5.0×FY 2017: 2.4×FY 2018: 4.3×FY 2019: 2.4×FY 2020: 21.8×FY 2021: 22.3×FY 2022: 14.3×FY 2023: 7.4×FY 2024: 7.1×FY 2025: 3.7×
FY 2016 5y median 7.4× FY 2025
Quick Ratio 3.7×
FY 2016: 5.0×FY 2017: 2.4×FY 2018: 4.3×FY 2019: 2.4×FY 2020: 21.8×FY 2021: 22.3×FY 2022: 14.3×FY 2023: 7.4×FY 2024: 7.1×FY 2025: 3.7×
FY 2016 5y median 7.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.8×FY 2017: 0.2×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.6×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 6.9×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.5×FY 2024: 1.1×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -29.2×FY 2017: -24.8×FY 2018: -671×FY 2019: 0.0×FY 2020: -9543×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 38.3%FY 2017: 225.5%FY 2018: 327.1%FY 2019: 327.2%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.7%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -61.8%FY 2017: -97.3%FY 2018: -147.3%FY 2019: -147.7%FY 2020: 0.0%FY 2021: -0.1%FY 2022: -1.1%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31